Armis Biopharma®

LATEST NEWS

January 22, 2024


Armis Biopharma® Announces the Addition of Two Key Executives to Enhance Commercialization of their Product Portfolio

Read More Here

September 28, 2023


Armis Biopharma® Announces Receipt of a Contract with the Defense Threat Reduction Agency to Develop Veriox® DECON for Battlefield Wounds

Read More Here

May 31, 2023


Armis Biopharma® Announces 510(k) Clearance for VeriCyn® Wound Wash



Read More Here

December 14, 2022


Veriox® DECON is Shown to Kill Biological Warfare Agent, Anthrax



Read More Here

August 15, 2022


Armis Biopharma® Announces Release of Phase 2 Grant Awardfrom the National Institutes of Health

Read More Here

May 31, 2023


Armis Biopharma® Announces 510(k) Clearance for VeriCyn® Wound Wash


Read More Here

September 23, 2021


Donates ArmiClenz® Disinfectant to Convoy of Hope for Hurricane Ida Victims


Read More Here

November 19, 2020


Armis Biopharma® Announces 510(k) Clearance for VeriFixx™ Small Bone Implant


Read More Here

November 9, 2020


Armis Biopharma® Announces Grant Awardfrom the National Institutes of Health


Read More Here